Journal of Law, Medicine & Ethics 2008-01-01

Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?

Keith C Ferdinand

Index: J. Law. Med. Ethics 36(3) , 458-63, (2008)

Full Text: HTML

Abstract

Race is not a scientific category, but African Americans have increased prevalence and severity of heart failure. The African American Heart Failure trial showed the benefit of a combination of isosorbide dinitrate (a nitric oxide donor) and hydralazine (an antioxidant). Future research may unmask the reason for cardiovascular differences in therapy.

Related Compounds

  • isosorbide dinitra...

Related Articles:

In vitro and in vivo evaluation of novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release.

2012-08-01

[Pharmazie 67(8) , 695-700, (2012)]

Superoxide dismutases, SOD1 and SOD2, play a distinct role in the fat body during pupation in silkworm Bombyx mori.

2015-01-01

[PLoS ONE 10(2) , e0116007, (2015)]

Early administration of isosorbide dinitrate improves survival of cyanide-poisoned rabbits.

2015-01-01

[Clin. Toxicol. (Phila.) 53(1) , 22-7, (2015)]

Headache response to nitrate in patients with coronary artery disease and systolic heart failure

2012-07-26

[Int. J. Cardiol. 158(3) , 453-4, (2012)]

A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer.

2012-11-01

[Ann. Oncol. 23(11) , 2925-30, (2012)]

More Articles...